Case report: Preliminary experience with organ-preserving treatment for locally advanced esophageal cancer in the immunotherapy era: a case series of four patients

Chemoimmunotherapy with selective radiotherapy may offer an organ-preserving opportunity for locally advanced esophageal cancer, with some patients achieving long-term recurrence-free survival. However, efficacy varies individually, and further optimization of treatment strategies is warranted.